Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-negative,ER-positive) and gBRCA or HDR-positive Metastatic Breast Cancer(LUZERN)
about
Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-negative,ER-positive) and gBRCA or HDR-positive Metastatic Breast Cancer(LUZERN)
description
clinical trial
@en
name
Niraparib Plus Aromatase Inhib ...... tastatic Breast Cancer(LUZERN)
@en
type
label
Niraparib Plus Aromatase Inhib ...... tastatic Breast Cancer(LUZERN)
@en
prefLabel
Niraparib Plus Aromatase Inhib ...... tastatic Breast Cancer(LUZERN)
@en
P4844
P1476
Multicenter, Open-label, Phase ...... Recombination Deficiency (HRD)
@en
P17
P1813
LUZERN
@en
P3098
NCT04240106
P580
2020-03-01T00:00:00Z
P582
2021-09-01T00:00:00Z